Prospective assessment of diagnostic efficacy and safety of Sonazoid(TM) and SonoVue(®) ultrasound contrast agents in patients with focal liver lesions

OBJECTIVES: To assess the respective diagnostic value of Sonazoid™ and SonoVue® for characterizing FLLs as benign or malignant and the corresponding safety. METHODS: This prospective Phase 3 study was conducted at 17 centres in China and Korea (May 2014 to April 2015); 424 patients (20 to 80 years)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Ke, Zhai, Hongyan, Jiang, Yuxin, Liang, Ping, Xu, Hui-Xiong, Du, Lianfang, Chou, Yi-Hong, Xie, Xiaoyan, Luo, YuKun, Lee, Young Joon, Lee, Jae Young, Hu, Bing, Luo, Baoming, Wang, Yi, Luan, Ying, Kalli, Christina, Chen, Kun, Wang, Wenping, Liang, Ja-Der
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Hepatobiliary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435522/
https://www.ncbi.nlm.nih.gov/pubmed/34136936
http://dx.doi.org/10.1007/s00261-021-03010-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435522/
https://www.ncbi.nlm.nih.gov/pubmed/34136936
http://dx.doi.org/10.1007/s00261-021-03010-1

Ejemplares similares